Director, MS Center for Innovations in Care. 🧠 doctor helping people live well with multiple sclerosis. Podcast host: apple.co/3mwg1Mo Tweets ≠ medical advice
St. Louis, MO USA
- Tweets 3,395
- Following 301
- Followers 7,709
- Likes 2,462
Pinned Tweet
NEW Podcast #GLP-1s, Weight and #Exercise in #MS
Impact on inflammation & neuroplasticity! Dr. Stuve @UTSWMedCenter & Trevor @MSGym1
bit.ly/4zNjTiT🍏apple.co/4iFQH7i
@narologist @jsabatino37 @C_OrejaGuevara @anneke_vdw #NeuroTwitter Sponsor: @TGTherapeutics
1
13
506
Worried your MS therapy raises your cancer risk? The long-term data may surprise you. New #MSLivingWell episode🎧Drs. Esther Melamed & Melinda Magyari; Host @brainboyneuro1
bit.ly/3TdjnKM 🍏apple.co/46HoeXF
@MStranslate @MustStopMS @themsguide @MarkWebb_
5
292
Worried your MS therapy raises your cancer risk? The long-term data may surprise you. New #MSLivingWell episode🎧Drs. Esther Melamed & Melinda Magyari; Host @brainboyneuro1
bit.ly/3TdjnKM 🍏apple.co/46HoeXF
@Brandon_Beaber @MSViewsandNews Sponsor: @TGTherapeutics
4
14
495
Can targeted exercise rewire the brain to improve function in #MS? Trevor Wicken @TheMSGym1 shares strategies on New MS Living Podcast.
bit.ly/4zNjTiT🍏apple.co/4iFQH7i
@MustStopMS @eurims @DrJNicholas @MarkWebb_
1
7
344
Could #GLP1 meds like Ozempic/Mounjaro do more for people with #MS than weight loss? Reduce inflammation, neuroprotection & myelin repair? New Podcast🎧 Guest: Dr. Stuve @UTSWMedCenter
bit.ly/4zNjTiT🍏apple.co/4iFQH7i
@Brandon_Beaber @MSViewsandNews @MStranslate
5
27
1,060
👏Phase 3 REMODEL #remibrutinib relapsing #MS: Superior⬇️ annualized relapse rate (ARR) & inflammatory brain lesions vs. teriflunomide. Positive trend in 3-month confirmed disability progression. Favorable safety profile with no liver safety signal. #BTKi bit.ly/4h6Douv
6
26
1,607
#CAREGIVING for someone with #MS? 🎧 Listen in to this new episode on MS Living Well podcast with @KennethPakenham, Dan Shaul & @brainboyneuro1
bit.ly/4pBqrg2 🍏apple.co/4fNsRoc
@KlausSchmierer @C_OrejaGuevara @anneke_vdw @bart_professor Sponsor: @TGTherapeutics
1
2
397
👫Caring for someone with MS? 🎧Tune into new Caregiving episode on MS Living Well podcast with @KennethPakenham & Dan Shaul. Host: @brainboyneuro1
bit.ly/4pBqrg2 🍏apple.co/4fNsRoc
@Brandon_Beaber @MustStopMS @MSViewsandNews @DanJenDig @MarkWebb_ @MStranslate
1
7
569
Working with #MS? 💼 From accommodations to long-term disability, understand your options! @brainboyneuro1 guests: #employment expert Dr. Rumrill & #disability attorney Jamie Hall.
bit.ly/3Qyknb3🍏apple.co/3STA9hg
#NeuroTwitter Sponsor: @TGTherapeutics @DrJim4MS
2
5
509
Worried about how #MS might affect your job? New MS Living Well podcast with #employment expert Dr. Phillip Rumrill & #disability attorney Jamie Hall.
🎧bit.ly/3Qyknb3🍏apple.co/3STA9hg
@DanJenDig @MarkWebb_ @Brandon_Beaber @MustStopMS @DocforMS @MSViewsandNews
3
6
810
New MRI techniques are uncovering hidden inflammation ongoing even when someone feels their MS is stable. New MS Living Well podcast 🎧
bit.ly/4dK0Ay8🍏apple.co/4vmB1sG
@brandon_beaber @MSViewsandNews @themsguide @MustStopMS @DocforMS @DrJim4MS @narologist
Made with AI
3
11
699
Beyond White Spots: Rethinking MRI in MS
New MS Living Well podcast 🎧 Profs. Barkhof & Traboulsee
bit.ly/4dK0Ay8🍏apple.co/4vmB1sG
@KlausSchmierer @C_OrejaGuevara @anneke_vdw @MSCanOfficial @MStranslate #neurotwitter Sponsor: @TGTherapeutics
1
4
465
Why can’t I find the right word?
In MS, it’s often not memory loss—it’s difficulty accessing info. New MS Living Well pod episode: Word-finding & memory strategies 🎧
bit.ly/4d6Js5e🍏bit.ly/4d6Js5e
@TrippingOnAir @MarkWebb_ @DamianWashington
@RachelHorne19
3
11
340
New MS Living Well podcast 🎧🗣️🧠
Handling MS: Word-Finding and Memory Strategies
with @jfsumowski & Dr. Barrera
bit.ly/4d6Js5e🍏bit.ly/4d6Js5e
Sponsor: @TGTherapeutics
@TheMSGuide @MSViewsandNews @SKriegerMD
1
291
You’re not losing your words—you’re having trouble accessing them. We dive into working memory & word-finding in MS—and what actually helps. New MS Living Well podcast 🎧
bit.ly/4d6Js5e🍏bit.ly/4d6Js5e
@C_OrejaGuevara @KlausSchmierer @MStranslate @MustStopMS
2
2
9
306
Phase 3 PERSEUS trial results in primary progressive multiple sclerosis #PPMS patients. No significant benefit of #tolebrutinib vs. placebo on primary endpoint of time to 6-month cCDP (disability measure). However, positive impact of brain volume.
@ACTRIMS #ACTRIMSForum
4
12
24
2,619
Phase 2 Relapsing #MS MoonStone 12-week results: 95% reduction in contrast-enhancing lesions compared to placebo.
#Obexelimab is a humanized monoclonal antibody that inhibits CD19 and FcyRllb
without inducing cytotoxicity.
@ACTRIMS #ACTRIMSForum
5
11
34
3,465
Phase III FENtrepid Study:
#Fenebritninb achieved noninferiority to ocrelizumab in reducing disability progression (cCDP12) in primary progressive multiple sclerosis #PPMS patients; actually 12% better. @ACTRIMS #ACTRIMSForum
8
15
35
5,600
Could an ingredient in walnuts help #MS? Dr. Jamie Holloman @brainboyneuro1 chats with Dr. Marianna Cortese and Dr. Eric Thouvenot. The Science of Supplements; a new MS Living Well podcast.
bit.ly/3X4Y4t5 🍏apple.co/4844DRE
@MSViewsandNews @lkay54 @DanJenDig
1
3
9
675
Curious about vitamins, nutrition & supplements for MS? New #MSLivingWell episode with Dr. Marianna Cortese & Dr. Eric Thouvenot, hosted by Dr. Jamie Holloman.
bit.ly/3X4Y4t5 🍏apple.co/4844DRE
@KlausSchmierer @C_OrejaGuevara @ConorKerley
Sponsor @TGTherapeutics
1
3
10
639